ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 407 filers reported holding ENCOMPASS HEALTH CORP in Q1 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $532 | -35.7% | 7,920 | -35.2% | 0.05% | -49.0% |
| Q2 2023 | $827 | -61.4% | 12,220 | -69.2% | 0.10% | -47.5% |
| Q1 2023 | $2,144 | -99.6% | 39,639 | +434.2% | 0.20% | +266.7% |
| Q4 2021 | $484,000 | -44.9% | 7,420 | -36.6% | 0.05% | -48.6% |
| Q3 2021 | $878,000 | +278.4% | 11,700 | +293.9% | 0.10% | +356.5% |
| Q2 2021 | $232,000 | -54.2% | 2,970 | -51.5% | 0.02% | -72.0% |
| Q4 2020 | $507,000 | -50.4% | 6,130 | -62.8% | 0.08% | -46.8% |
| Q2 2020 | $1,022,000 | +81.9% | 16,500 | +103.3% | 0.15% | +71.1% |
| Q4 2019 | $562,000 | +77.3% | 8,116 | +62.2% | 0.09% | +69.8% |
| Q2 2019 | $317,000 | -5.4% | 5,005 | -12.7% | 0.05% | -3.6% |
| Q1 2019 | $335,000 | -66.5% | 5,733 | -64.6% | 0.06% | -68.2% |
| Q4 2018 | $999,000 | -22.4% | 16,194 | -1.9% | 0.17% | -3.4% |
| Q3 2018 | $1,287,000 | +273.0% | 16,510 | +224.1% | 0.18% | +244.2% |
| Q2 2018 | $345,000 | -14.2% | 5,094 | -27.5% | 0.05% | -13.3% |
| Q1 2018 | $402,000 | – | 7,023 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 798,931 | $53,656,206 | 4.60% |
| Orchard Capital Management, LLC | 135,466 | $9,097,897 | 3.36% |
| Sivik Global Healthcare LLC | 90,000 | $6,044 | 3.05% |
| BERNZOTT CAPITAL ADVISORS | 128,663 | $8,641,007 | 2.98% |
| REINHART PARTNERS, LLC. | 746,752 | $50,151,893 | 2.60% |
| Integral Health Asset Management, LLC | 250,000 | $16,790,000 | 2.32% |
| Leeward Investments, LLC - MA | 562,001 | $37,743,987 | 1.93% |
| Copeland Capital Management, LLC | 1,277,690 | $85,809,665 | 1.84% |
| Magnetar Financial LLC | 1,060,733 | $71,238,828 | 1.82% |
| Advantage Alpha Capital Partners LP | 122,252 | $8,210,444 | 1.72% |